WIPIT Advises Cellbox Solutions on €5 Million Series A Financing Round

Following the first closing of approximately €3.5 million in March 2026, Cellbox Solutions successfully attracted additional investors. The new investors include members of Baltic Business Angels Schleswig-Holstein e.V., a Canadian family office, and an undisclosed investor with extensive experience in pharmaceutical logistics. Existing investors NRW.BANK and Fraunhofer Venture also participated in the financing round. The first closing in March was led by Companisto.

Founded in 2017, Cellbox Solutions GmbH is a German technology company specializing in innovative temperature-controlled logistics solutions for the healthcare and life sciences industries. The company develops technologies for the safe transportation of sensitive biological materials and therapeutics that cannot be frozen and require controlled biological conditions.

With the additional capital, Cellbox Solutions will further develop its business model and expand its portfolio to include integrated logistics solutions for cells, tissues, organoids, and other sensitive biological materials.

The WIPIT team was led by Prof. Dr. Hans-Eric Rasmussen-Bonne (Partner, Venture Capital, Berlin), supported by Marius Tauchmann (Salary Partner, Venture Capital, Munich).

WIPIT would like to thank Prof. Dr. Kathrin Adlkofer and Dr. Bernd Muehlenweg for their trust and the excellent collaboration throughout the transaction.

We congratulate the entire Cellbox Solutions team on the successful financing round and wish them continued success in their next phase of growth.

‍